Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 11, 1997

View Archived Issues

Takeda reports MIP-1alpha/RANTES receptor antagonists

New hydroxamic acid compounds inhibiting TNF, PDE IV and/or MMPs

SKB patents several series of vitronectin receptor antagonists

New opioid analgesics from Astra

New atypical antipsychotic agent from HMR

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Novartis launches Exelon

Topical foscarnet for treatment of herpes labialis

MiniMed and LRX combine forces for pulmonary hypertension treatment

AMO Array Multifocal IOL approved for marketing in U.S.

PharmaPrint begins phase II trial of herbal treatment for BPH

Lark signs DNA sequencing agreement with ZymoGenetics

Expanded uses of LifeCell's AlloDerm discussed at recent meeting

Geron awarded SBIR grant for development of telomerase-based diagnostics

IDEC licenses rights to novel antiinflammatory technology

Promising initial results reported for VasoCare therapy in Raynaud's disease

Final phase I/IIa data reported on oral Panretin in APL

Oxygent enhances oxygenation more effectively than blood in surgical patients

Meridian's rapid test for rotavirus approved by FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...